Work

MA12.03 PARP Inhibitor Sensitivity Does Not Depend on BAP1 but Is Enhanced by Temozolomide in MGMT Deficient Human Mesothelioma Cells

Year: 2019

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.08.594

Authors: D. Rathkey, M. Khanal, J. Murai, J. Zhang, Q. Jiang, B. Morrow, C. Evans, R. Chari, M. Sengupta, A. Thomas, Y. Pommier, R. Hassan

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Japan Society for the Promotion of Science

Award: Development of SLFN11 as a tumor supressor gene

OpenAlex ID: W2982052515

Cites:

Cited by: 1

Related to: 10